Hepatitis B surface antigen recombinant - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
H-B-VAX II hepatitis B vaccine recombinant 40 microgram/1mL injection vial (thiomersal free) AUST R: 90623Active ingredients:
Hepatitis B surface antigen recombinant
Dosage form:
Injection, suspension
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
1800818553
|
From
23 Mar 2026
to
31 May 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Unexpected increase in consumer demand
Management action:
Sponsor is working to expedite the next shipment.
|
TWINRIX JUNIOR (combined hepatitis A & hepatitis B vaccine) 0.5 mL injection pre-filled syringe thiomersal & preservative free AUST R: 140576Active ingredients:
Hepatitis a virus antigen
Hepatitis B surface antigen recombinant
Dosage form:
Injection, suspension
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
01 Jul 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
|